Abediterol

Abediterol
Names
	IUPAC name (R)-5-(2-((6-(2,2-difluoro-2-phenylethoxy)hexyl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
Identifiers
CAS Number	915133-65-2 ;
3D model (JSmol)	Interactive image;
UNII	QXA167CM6F;
CompTox Dashboard (EPA)	DTXSID60238605 ;
	SMILES FC(COCCCCCCNC[C@H](O)C1=C(C=CC(N2)=O)C2=C(O)C=C1)(F)C3=CC=CC=C3;
Properties
Chemical formula	C25H30F2N2O4
Molar mass	460.522 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Abediterol (INN^[1]) is an experimental drug candidate for the treatment of asthma and chronic obstructive pulmonary disease. It is currently under development by the Spanish pharmaceutical company Almirall and is in Phase II clinical trials.^[2] It acts as a muscarinic antagonist and a β₂-adrenergic agonist.^[3]^[4]

References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.